Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | TP53 |
Variant | R175H |
Impact List | missense |
Protein Effect | loss of function |
Gene Variant Descriptions | TP53 R175H is a hotspot mutation that lies within the DNA binding domain of the Tp53 protein (PMID: 22713868). R175H leads to increased Nek2 expression in culture (PMID: 35088582) and results in a loss of DNA binding, decreased activation of Tp53 targets and interferes with activation by wild-type Tp53, resistance to apoptosis, failure of G1 arrest, decreased genomic stability, promotes tumorigenesis, proliferation, migration, invasion, and stability, and additionally confers a gain of function to Tp53, resulting in aberrant activation of gene transcription and enhanced cell migration (PMID: 10713666, PMID: 22114072, PMID: 19881536, PMID: 14743206, PMID: 31395785, PMID: 37030635). |
Associated Drug Resistance | |
Category Variants Paths |
TP53 mutant TP53 exon5 TP53 R175X TP53 R175H TP53 mutant TP53 inact mut TP53 R175H |
Transcript | NM_000546.6 |
gDNA | chr17:g.7675088C>T |
cDNA | c.524G>A |
Protein | p.R175H |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001407270.1 | chr17:g.7675088C>T | c.524G>A | p.R175H | RefSeq | GRCh38/hg38 |
NM_001126112.3 | chr17:g.7675088C>T | c.524G>A | p.R175H | RefSeq | GRCh38/hg38 |
NM_001126114.2 | chr17:g.7675088C>T | c.524G>A | p.R175H | RefSeq | GRCh38/hg38 |
NM_001126113.2 | chr17:g.7675088C>T | c.524G>A | p.R175H | RefSeq | GRCh38/hg38 |
NM_001126114.3 | chr17:g.7675088C>T | c.524G>A | p.R175H | RefSeq | GRCh38/hg38 |
NM_001126113.3 | chr17:g.7675088C>T | c.524G>A | p.R175H | RefSeq | GRCh38/hg38 |
NM_001407264.1 | chr17:g.7675088C>T | c.524G>A | p.R175H | RefSeq | GRCh38/hg38 |
NM_001126112.2 | chr17:g.7675088C>T | c.524G>A | p.R175H | RefSeq | GRCh38/hg38 |
NM_001407268.1 | chr17:g.7675088C>T | c.524G>A | p.R175H | RefSeq | GRCh38/hg38 |
NM_001407266.1 | chr17:g.7675088C>T | c.524G>A | p.R175H | RefSeq | GRCh38/hg38 |
NM_001126114 | chr17:g.7675088C>T | c.524G>A | p.R175H | RefSeq | GRCh38/hg38 |
NM_001126112 | chr17:g.7675088C>T | c.524G>A | p.R175H | RefSeq | GRCh38/hg38 |
NM_000546 | chr17:g.7675088C>T | c.524G>A | p.R175H | RefSeq | GRCh38/hg38 |
NM_001126113 | chr17:g.7675088C>T | c.524G>A | p.R175H | RefSeq | GRCh38/hg38 |
NM_000546.5 | chr17:g.7675088C>T | c.524G>A | p.R175H | RefSeq | GRCh38/hg38 |
NM_001407262.1 | chr17:g.7675088C>T | c.524G>A | p.R175H | RefSeq | GRCh38/hg38 |
NM_000546.6 | chr17:g.7675088C>T | c.524G>A | p.R175H | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05877599 | Phase I | NT-175 | A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation | Recruiting | USA | 0 |
NCT06690281 | Phase II | Cyclophosphamide + Fludarabine Aldesleukin + Autologous KRAS mutant TCR-transduced PBLs | A Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With Advanced Gastrointestinal Malignancies | Not yet recruiting | USA | 0 |